PL338434A1 - Pharmacologically advantagenous crystalline form of (-)-(s)-bromophosphamide, method of obtaining same and solid oral administration dosage form of drugs containing ite - Google Patents

Pharmacologically advantagenous crystalline form of (-)-(s)-bromophosphamide, method of obtaining same and solid oral administration dosage form of drugs containing ite

Info

Publication number
PL338434A1
PL338434A1 PL33843400A PL33843400A PL338434A1 PL 338434 A1 PL338434 A1 PL 338434A1 PL 33843400 A PL33843400 A PL 33843400A PL 33843400 A PL33843400 A PL 33843400A PL 338434 A1 PL338434 A1 PL 338434A1
Authority
PL
Poland
Prior art keywords
advantagenous
bromophosphamide
pharmacologically
oral administration
solid oral
Prior art date
Application number
PL33843400A
Other versions
PL195489B1 (en
Inventor
Wojciech J Stec
Wieslaw Szelejewski
Czeslaw Radzikowski
Andrzej Kutner
Grzegorz Grynkiewicz
Andrzej Zaremba
Stanislaw Adamski
Miroslaw Popielarczyk
Original Assignee
Inst Farmaceutyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Farmaceutyczny filed Critical Inst Farmaceutyczny
Priority to PL338434A priority Critical patent/PL195489B1/en
Publication of PL338434A1 publication Critical patent/PL338434A1/en
Publication of PL195489B1 publication Critical patent/PL195489B1/en

Links

PL338434A 2000-02-15 2000-02-15 Pharmacologically advantagenous crystalline form of (-)-(s)-bromophosphamide, method of obtaining same and solid oral administration dosage form of drugs containing ite PL195489B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL338434A PL195489B1 (en) 2000-02-15 2000-02-15 Pharmacologically advantagenous crystalline form of (-)-(s)-bromophosphamide, method of obtaining same and solid oral administration dosage form of drugs containing ite

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL338434A PL195489B1 (en) 2000-02-15 2000-02-15 Pharmacologically advantagenous crystalline form of (-)-(s)-bromophosphamide, method of obtaining same and solid oral administration dosage form of drugs containing ite

Publications (2)

Publication Number Publication Date
PL338434A1 true PL338434A1 (en) 2001-08-27
PL195489B1 PL195489B1 (en) 2007-09-28

Family

ID=20076053

Family Applications (1)

Application Number Title Priority Date Filing Date
PL338434A PL195489B1 (en) 2000-02-15 2000-02-15 Pharmacologically advantagenous crystalline form of (-)-(s)-bromophosphamide, method of obtaining same and solid oral administration dosage form of drugs containing ite

Country Status (1)

Country Link
PL (1) PL195489B1 (en)

Also Published As

Publication number Publication date
PL195489B1 (en) 2007-09-28

Similar Documents

Publication Publication Date Title
PL356358A1 (en) Solid dosage form of someticone for oral administration
PL333524A1 (en) Improved prolonged release pharmaceutic preparation for administration of nephadosone, oral dosage form thereof and improved nephadosone administration method
HUP0302319A3 (en) Pharmaceutical composition for oral administration of active ingredient
PL396568A1 (en) Crystalline O-desmethyl-venlafaxine succinate, the pharmaceutical composition, pharmaceutical dosage form, oral dosage form, application and process for the preparation of crystalline O-desmethyl-venlafaxine succinate
HK1047231A1 (en) Oral pharmaceutical forms of administration with adelayed action with tramadol
HUP0101246A3 (en) Novel galenic formulations of meloxicam for oral administration and process for their preparation
HUP0303800A3 (en) Pharmaceuticals and dosage forms of epothilones for oral administration
IL166489A (en) Two-layerd oral dosage form for once-a-day administration of paliperidone and uses thereof
EP1365747A4 (en) Oral peptide pharmaceutical dosage form and method of production
AU2001283563A1 (en) Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
AU2002357012A1 (en) Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
DE69936002D1 (en) ADJUSTED SPOON FOR ORAL MEDICAMENT ADMINISTRATION
HUP0402451A3 (en) Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
MXPA02003596A (en) Novel pharmaceutical compositions of anti-tubercular drugs and process for their preparation.
EP1372392A4 (en) Nicotine-containing oral dosage form
PL344564A1 (en) Matrix tablet enabling prolonged release of trimethiazidine after oral administration and method of making such tablet
IL145559A0 (en) Tolperison-containing pharmaceutical preparation for oral administration
SG116507A1 (en) Pharmaceutical dosage form and method of making.
NZ507968A (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
EP1207852A4 (en) Controlled release oral dosage suitable for oral administration
HUP0302050A3 (en) Pharmaceutical form of administration for peptides, method for its production and use
HUP0201667A3 (en) Oral form of administration
PL338434A1 (en) Pharmacologically advantagenous crystalline form of (-)-(s)-bromophosphamide, method of obtaining same and solid oral administration dosage form of drugs containing ite
AU2003284786A8 (en) Microemulsion composition for oral administration of biphenyldimethyldicarboxylate
AU2003256157A1 (en) Oral dosage forms of water insoluble drugs and methods of making the same